186 related articles for article (PubMed ID: 38432118)
1. Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus.
Yang JJ; Goff A; Wild DJ; Ding Y; Annis A; Kerber R; Foote B; Passi A; Duerksen JL; London S; Puhl AC; Lane TR; Braunstein M; Waddell SJ; Ekins S
Tuberculosis (Edinb); 2024 May; 146():102500. PubMed ID: 38432118
[TBL] [Abstract][Full Text] [Related]
2. A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.
Park J; Kwak N; Chae JC; Yoon EJ; Jeong SH
Microbiol Spectr; 2023 Aug; 11(4):e0160623. PubMed ID: 37378523
[TBL] [Abstract][Full Text] [Related]
3. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
[TBL] [Abstract][Full Text] [Related]
4. Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
Addo KK; Addo SO; Mensah GI; Mosi L; Bonsu FA
BMC Infect Dis; 2017 Dec; 17(1):743. PubMed ID: 29197331
[TBL] [Abstract][Full Text] [Related]
5. Sudapyridine (WX-081) antibacterial activity against
Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium abscessus drug discovery using machine learning.
Schmalstig AA; Zorn KM; Murcia S; Robinson A; Savina S; Komarova E; Makarov V; Braunstein M; Ekins S
Tuberculosis (Edinb); 2022 Jan; 132():102168. PubMed ID: 35077930
[TBL] [Abstract][Full Text] [Related]
7. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632
[TBL] [Abstract][Full Text] [Related]
8. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
[TBL] [Abstract][Full Text] [Related]
9. Development of a One-Step Multiplex PCR Assay for Differential Detection of Major Mycobacterium Species.
Chae H; Han SJ; Kim SY; Ki CS; Huh HJ; Yong D; Koh WJ; Shin SJ
J Clin Microbiol; 2017 Sep; 55(9):2736-2751. PubMed ID: 28659320
[TBL] [Abstract][Full Text] [Related]
10. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
[No Abstract] [Full Text] [Related]
11. Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings.
Keerthirathne TP; Magana-Arachchi DN; Madegedara D; Sooriyapathirana SS
BMC Infect Dis; 2016 Oct; 16(1):607. PubMed ID: 27782812
[TBL] [Abstract][Full Text] [Related]
12. Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.
Gupta R; Rodrigues Felix C; Akerman MP; Akerman KJ; Slabber CA; Wang W; Adams J; Shaw LN; Tse-Dinh YC; Munro OQ; Rohde KH
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483110
[No Abstract] [Full Text] [Related]
13. Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus
Sarathy JP; Zimmerman MD; Gengenbacher M; Dartois V; Dick T
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0123722. PubMed ID: 36350151
[TBL] [Abstract][Full Text] [Related]
14. Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
Gross JE; Caceres S; Poch K; Hasan NA; Jia F; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA
Am J Respir Crit Care Med; 2022 May; 205(9):1064-1074. PubMed ID: 35085056
[No Abstract] [Full Text] [Related]
15. The
Williams JT; Giletto M; Haiderer ER; Aleiwi B; Krieger-Burke T; Ellsworth E; Abramovitch RB
Microbiol Spectr; 2024 Jan; 12(1):e0367723. PubMed ID: 38078724
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mycobacterium abscessus Activity of Tuberculosis F-ATP Synthase Inhibitor GaMF1.
Ragunathan P; Dick T; Grüber G
Antimicrob Agents Chemother; 2022 May; 66(5):e0001822. PubMed ID: 35481752
[TBL] [Abstract][Full Text] [Related]
17. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR
PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India.
Das S; Mishra B; Mohapatra PR; Preetam C; Rath S
Int J Mycobacteriol; 2022; 11(2):167-174. PubMed ID: 35775549
[TBL] [Abstract][Full Text] [Related]
19. Rifabutin Is Active against Mycobacterium abscessus in Mice.
Dick T; Shin SJ; Koh WJ; Dartois V; Gengenbacher M
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767722
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial properties of basidiomycota macrofungi to
Millar BC; Nelson D; Moore RE; Rao JR; Moore JE
Int J Mycobacteriol; 2019; 8(1):93-97. PubMed ID: 30860186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
